Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,073 | -33,470 | -25,048 | -16,048 | -8,006 |
| Depreciation Amortization | 66 | 240 | 195 | 127 | 63 |
| Accounts payable and accrued liabilities | -1,077 | 586 | 864 | 562 | 495 |
| Other Working Capital | 823 | 1,870 | 1,737 | 1,214 | 1,473 |
| Other Operating Activity | 1,694 | 1,244 | 461 | 293 | -92 |
| Operating Cash Flow | $-7,567 | $-29,530 | $-21,791 | $-13,852 | $-6,067 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,804 | 25,092 | 18,244 | 11,459 | 3,054 |
| PPE Investments | -33 | -520 | -515 | -164 | -41 |
| Other Investing Activity | 0 | -12 | 0 | 0 | 0 |
| Investing Cash Flow | $3,771 | $24,560 | $17,729 | $11,295 | $3,013 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,338 | 3,514 | 586 | N/A | N/A |
| Debt Repayment | -1,800 | -600 | N/A | N/A | N/A |
| Common Stock Issued | -297 | 10 | 10 | 9 | 3 |
| Other Financing Activity | 0 | -594 | -596 | -325 | -296 |
| Financing Cash Flow | $5,241 | $2,330 | $N/A | $-316 | $-293 |
| Beginning Cash Position | 5,510 | 8,150 | 8,150 | 8,150 | 8,150 |
| End Cash Position | 6,955 | 5,510 | 4,088 | 5,277 | 4,803 |
| Net Cash Flow | $1,445 | $-2,640 | $-4,062 | $-2,873 | $-3,347 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,567 | -29,530 | -21,791 | -13,852 | -6,067 |
| Capital Expenditure | -53 | -525 | -515 | -164 | -41 |
| Free Cash Flow | -7,620 | -30,055 | -22,306 | -14,016 | -6,108 |